Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Olga Benítez Hidalgo: New Evidence on Marstacimab in Hemophilia Care
Jun 13, 2026, 14:58

Olga Benítez Hidalgo: New Evidence on Marstacimab in Hemophilia Care

Olga Benítez Hidalgo, Board of Directors at Spanish Society of Thrombosis and Hemostasis, Hematologist at Vall d’Hebron Barcelona Hospital Campus, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Thrombosis and Haemostasis:

“Published in the Journal of Thrombosis and Haemostasis: phase 3 BASIS study analysis on the management of breakthrough bleeds and surgical procedures in people with hemophilia A or B without inhibitors receiving marstacimab prophylaxis.

As non-factor prophylactic therapies continue to expand the treatment landscape in hemophilia, generating practical evidence for the management of real-world clinical situations – including bleeding episodes and procedures – is essential.

Proud to contribute to this collaborative clinical research effort.”

Title: Management of breakthrough bleeds and surgical procedures in participants with hemophilia A or B without inhibitors receiving marstacimab prophylaxis in the phase 3 BASIS study

Authors: Johnny Mahlangu, Davide Matino, Olga Benítez Hidalgo, Travis Gould, Hae Kyung Kim, Pengling Sun, Carrie Turich Taylor, Andrew Palladino

Olga Benítez Hidalgo: New Evidence on Marstacimab in Hemophilia Care

Stay updated with Hemostasis Today.